<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2001-10-18" modified="2020-10-07" version="204">
<accession>Q99836</accession>
<accession>B4DKH8</accession>
<accession>B4DKU4</accession>
<accession>B4DQ60</accession>
<accession>B4DQ72</accession>
<accession>J3KPU4</accession>
<accession>J3KQ87</accession>
<accession>J3KQJ6</accession>
<accession>P78397</accession>
<accession>Q53XS7</accession>
<name>MYD88_HUMAN</name>
<protein>
<recommendedName>
<fullName>Myeloid differentiation primary response protein MyD88</fullName>
</recommendedName>
</protein>
<gene>
<name type="primary" evidence="36">MYD88</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1996" name="Oncogene" volume="13" first="2467" last="2475">
<title>Molecular characterization and modular analysis of human MyD88.</title>
<authorList>
<person name="Hardiman G."/>
<person name="Rock F.L."/>
<person name="Balasubramanian S."/>
<person name="Kastelein R.A."/>
<person name="Bazan J.F."/>
</authorList>
<dbReference type="PubMed" id="8957090"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>VARIANT CYS-98</scope>
<source>
<tissue>Dendritic cell</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1997" name="FEBS Lett." volume="402" first="81" last="84">
<title>The cloning and characterization of human MyD88: a member of an IL-1 receptor related family.</title>
<authorList>
<person name="Bonnert T.P."/>
<person name="Garka K.E."/>
<person name="Parnet P."/>
<person name="Sonoda G."/>
<person name="Testa J.R."/>
<person name="Sims J.E."/>
</authorList>
<dbReference type="PubMed" id="9013863"/>
<dbReference type="DOI" id="10.1016/s0014-5793(96)01506-2"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>FUNCTION</scope>
<source>
<tissue>Epidermal carcinoma</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2008" name="Immunogenetics" volume="60" first="727" last="735">
<title>Natural selection in the TLR-related genes in the course of primate evolution.</title>
<authorList>
<person name="Nakajima T."/>
<person name="Ohtani H."/>
<person name="Satta Y."/>
<person name="Uno Y."/>
<person name="Akari H."/>
<person name="Ishida T."/>
<person name="Kimura A."/>
</authorList>
<dbReference type="PubMed" id="18810425"/>
<dbReference type="DOI" id="10.1007/s00251-008-0332-0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="4">
<citation type="submission" date="2003-05" db="EMBL/GenBank/DDBJ databases">
<title>Cloning of human full-length CDSs in BD Creator(TM) system donor vector.</title>
<authorList>
<person name="Kalnine N."/>
<person name="Chen X."/>
<person name="Rolfs A."/>
<person name="Halleck A."/>
<person name="Hines L."/>
<person name="Eisenstein S."/>
<person name="Koundinya M."/>
<person name="Raphael J."/>
<person name="Moreira D."/>
<person name="Kelley T."/>
<person name="LaBaer J."/>
<person name="Lin Y."/>
<person name="Phelan M."/>
<person name="Farmer A."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2; 3; 4 AND 5)</scope>
<source>
<tissue>Umbilical cord blood</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="2006" name="Nature" volume="440" first="1194" last="1198">
<title>The DNA sequence, annotation and analysis of human chromosome 3.</title>
<authorList>
<person name="Muzny D.M."/>
<person name="Scherer S.E."/>
<person name="Kaul R."/>
<person name="Wang J."/>
<person name="Yu J."/>
<person name="Sudbrak R."/>
<person name="Buhay C.J."/>
<person name="Chen R."/>
<person name="Cree A."/>
<person name="Ding Y."/>
<person name="Dugan-Rocha S."/>
<person name="Gill R."/>
<person name="Gunaratne P."/>
<person name="Harris R.A."/>
<person name="Hawes A.C."/>
<person name="Hernandez J."/>
<person name="Hodgson A.V."/>
<person name="Hume J."/>
<person name="Jackson A."/>
<person name="Khan Z.M."/>
<person name="Kovar-Smith C."/>
<person name="Lewis L.R."/>
<person name="Lozado R.J."/>
<person name="Metzker M.L."/>
<person name="Milosavljevic A."/>
<person name="Miner G.R."/>
<person name="Morgan M.B."/>
<person name="Nazareth L.V."/>
<person name="Scott G."/>
<person name="Sodergren E."/>
<person name="Song X.-Z."/>
<person name="Steffen D."/>
<person name="Wei S."/>
<person name="Wheeler D.A."/>
<person name="Wright M.W."/>
<person name="Worley K.C."/>
<person name="Yuan Y."/>
<person name="Zhang Z."/>
<person name="Adams C.Q."/>
<person name="Ansari-Lari M.A."/>
<person name="Ayele M."/>
<person name="Brown M.J."/>
<person name="Chen G."/>
<person name="Chen Z."/>
<person name="Clendenning J."/>
<person name="Clerc-Blankenburg K.P."/>
<person name="Chen R."/>
<person name="Chen Z."/>
<person name="Davis C."/>
<person name="Delgado O."/>
<person name="Dinh H.H."/>
<person name="Dong W."/>
<person name="Draper H."/>
<person name="Ernst S."/>
<person name="Fu G."/>
<person name="Gonzalez-Garay M.L."/>
<person name="Garcia D.K."/>
<person name="Gillett W."/>
<person name="Gu J."/>
<person name="Hao B."/>
<person name="Haugen E."/>
<person name="Havlak P."/>
<person name="He X."/>
<person name="Hennig S."/>
<person name="Hu S."/>
<person name="Huang W."/>
<person name="Jackson L.R."/>
<person name="Jacob L.S."/>
<person name="Kelly S.H."/>
<person name="Kube M."/>
<person name="Levy R."/>
<person name="Li Z."/>
<person name="Liu B."/>
<person name="Liu J."/>
<person name="Liu W."/>
<person name="Lu J."/>
<person name="Maheshwari M."/>
<person name="Nguyen B.-V."/>
<person name="Okwuonu G.O."/>
<person name="Palmeiri A."/>
<person name="Pasternak S."/>
<person name="Perez L.M."/>
<person name="Phelps K.A."/>
<person name="Plopper F.J."/>
<person name="Qiang B."/>
<person name="Raymond C."/>
<person name="Rodriguez R."/>
<person name="Saenphimmachak C."/>
<person name="Santibanez J."/>
<person name="Shen H."/>
<person name="Shen Y."/>
<person name="Subramanian S."/>
<person name="Tabor P.E."/>
<person name="Verduzco D."/>
<person name="Waldron L."/>
<person name="Wang J."/>
<person name="Wang J."/>
<person name="Wang Q."/>
<person name="Williams G.A."/>
<person name="Wong G.K.-S."/>
<person name="Yao Z."/>
<person name="Zhang J."/>
<person name="Zhang X."/>
<person name="Zhao G."/>
<person name="Zhou J."/>
<person name="Zhou Y."/>
<person name="Nelson D."/>
<person name="Lehrach H."/>
<person name="Reinhardt R."/>
<person name="Naylor S.L."/>
<person name="Yang H."/>
<person name="Olson M."/>
<person name="Weinstock G."/>
<person name="Gibbs R.A."/>
</authorList>
<dbReference type="PubMed" id="16641997"/>
<dbReference type="DOI" id="10.1038/nature04728"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 190-224 (ISOFORM 6)</scope>
<source>
<tissue>Pancreas</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="2004" name="Nat. Immunol." volume="5" first="1061" last="1068">
<title>Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6.</title>
<authorList>
<person name="Kawai T."/>
<person name="Sato S."/>
<person name="Ishii K.J."/>
<person name="Coban C."/>
<person name="Hemmi H."/>
<person name="Yamamoto M."/>
<person name="Terai K."/>
<person name="Matsuda M."/>
<person name="Inoue J."/>
<person name="Uematsu S."/>
<person name="Takeuchi O."/>
<person name="Akira S."/>
</authorList>
<dbReference type="PubMed" id="15361868"/>
<dbReference type="DOI" id="10.1038/ni1118"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH IRF7</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2004" name="Proc. Natl. Acad. Sci. U.S.A." volume="101" first="15416" last="15421">
<title>Role of a transductional-transcriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signaling.</title>
<authorList>
<person name="Honda K."/>
<person name="Yanai H."/>
<person name="Mizutani T."/>
<person name="Negishi H."/>
<person name="Shimada N."/>
<person name="Suzuki N."/>
<person name="Ohba Y."/>
<person name="Takaoka A."/>
<person name="Yeh W.C."/>
<person name="Taniguchi T."/>
</authorList>
<dbReference type="PubMed" id="15492225"/>
<dbReference type="DOI" id="10.1073/pnas.0406933101"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH IRF7</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2005" name="Immunity" volume="23" first="479" last="490">
<title>IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST 2 and induces T helper type 2-associated cytokines.</title>
<authorList>
<person name="Schmitz J."/>
<person name="Owyang A."/>
<person name="Oldham E."/>
<person name="Song Y."/>
<person name="Murphy E."/>
<person name="McClanahan T.K."/>
<person name="Zurawski G."/>
<person name="Moshrefi M."/>
<person name="Qin J."/>
<person name="Li X."/>
<person name="Gorman D.M."/>
<person name="Bazan J.F."/>
<person name="Kastelein R.A."/>
</authorList>
<dbReference type="PubMed" id="16286016"/>
<dbReference type="DOI" id="10.1016/j.immuni.2005.09.015"/>
</citation>
<scope>INTERACTION WITH IL1RL1</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2006" name="Nat. Immunol." volume="7" first="1057" last="1065">
<title>Smad6 negatively regulates interleukin 1-receptor-Toll-like receptor signaling through direct interaction with the adapter Pellino-1.</title>
<authorList>
<person name="Choi K.C."/>
<person name="Lee Y.S."/>
<person name="Lim S."/>
<person name="Choi H.K."/>
<person name="Lee C.H."/>
<person name="Lee E.K."/>
<person name="Hong S."/>
<person name="Kim I.H."/>
<person name="Kim S.J."/>
<person name="Park S.H."/>
</authorList>
<dbReference type="PubMed" id="16951688"/>
<dbReference type="DOI" id="10.1038/ni1383"/>
</citation>
<scope>IDENTIFICATION IN COMPLEX WITH IRAK1; IRAK4; TRAF6 AND PELI1</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2008" name="J. Immunol." volume="180" first="3485" last="3491">
<title>Etk/BMX, a Btk family tyrosine kinase, and Mal contribute to the cross-talk between MyD88 and FAK pathways.</title>
<authorList>
<person name="Semaan N."/>
<person name="Alsaleh G."/>
<person name="Gottenberg J.E."/>
<person name="Wachsmann D."/>
<person name="Sibilia J."/>
</authorList>
<dbReference type="PubMed" id="18292575"/>
<dbReference type="DOI" id="10.4049/jimmunol.180.5.3485"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH BMX</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2009" name="J. Immunol." volume="182" first="3450" last="3460">
<title>Modulation of TLR signaling by multiple MyD88-interacting partners including leucine-rich repeat Fli-I-interacting proteins.</title>
<authorList>
<person name="Dai P."/>
<person name="Jeong S.Y."/>
<person name="Yu Y."/>
<person name="Leng T."/>
<person name="Wu W."/>
<person name="Xie L."/>
<person name="Chen X."/>
</authorList>
<dbReference type="PubMed" id="19265123"/>
<dbReference type="DOI" id="10.4049/jimmunol.0802260"/>
</citation>
<scope>INTERACTION WITH FLII; LRRFIP1 AND LRRFIP2</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="37570" last="37578">
<title>TRIF mediates Toll-like receptor 5-induced signaling in intestinal epithelial cells.</title>
<authorList>
<person name="Choi Y.J."/>
<person name="Im E."/>
<person name="Chung H.K."/>
<person name="Pothoulakis C."/>
<person name="Rhee S.H."/>
</authorList>
<dbReference type="PubMed" id="20855887"/>
<dbReference type="DOI" id="10.1074/jbc.m110.158394"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH TLR5</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="3750" last="3757">
<title>AIP1 functions as Arf6-GAP to negatively regulate TLR4 signaling.</title>
<authorList>
<person name="Wan T."/>
<person name="Liu T."/>
<person name="Zhang H."/>
<person name="Tang S."/>
<person name="Min W."/>
</authorList>
<dbReference type="PubMed" id="19948740"/>
<dbReference type="DOI" id="10.1074/jbc.m109.069385"/>
</citation>
<scope>INTERACTION WITH TIRAP</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2010" name="Proc. Natl. Acad. Sci. U.S.A." volume="107" first="15181" last="15186">
<title>Aspartate-glutamate-alanine-histidine box motif (DEAH)/RNA helicase A helicases sense microbial DNA in human plasmacytoid dendritic cells.</title>
<authorList>
<person name="Kim T."/>
<person name="Pazhoor S."/>
<person name="Bao M."/>
<person name="Zhang Z."/>
<person name="Hanabuchi S."/>
<person name="Facchinetti V."/>
<person name="Bover L."/>
<person name="Plumas J."/>
<person name="Chaperot L."/>
<person name="Qin J."/>
<person name="Liu Y.J."/>
</authorList>
<dbReference type="PubMed" id="20696886"/>
<dbReference type="DOI" id="10.1073/pnas.1006539107"/>
</citation>
<scope>INTERACTION WITH DHX9</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="1341" last="1353">
<title>Two human MYD88 variants, S34Y and R98C, interfere with MyD88-IRAK4-myddosome assembly.</title>
<authorList>
<person name="George J."/>
<person name="Motshwene P.G."/>
<person name="Wang H."/>
<person name="Kubarenko A.V."/>
<person name="Rautanen A."/>
<person name="Mills T.C."/>
<person name="Hill A.V."/>
<person name="Gay N.J."/>
<person name="Weber A.N."/>
</authorList>
<dbReference type="PubMed" id="20966070"/>
<dbReference type="DOI" id="10.1074/jbc.m110.159996"/>
</citation>
<scope>INTERACTION WITH IRAK4</scope>
<scope>CHARACTERIZATION OF VARIANTS TYR-34; CYS-98 AND ILE-178</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2011" name="Nature" volume="470" first="115" last="119">
<title>Oncogenically active MYD88 mutations in human lymphoma.</title>
<authorList>
<person name="Ngo V.N."/>
<person name="Young R.M."/>
<person name="Schmitz R."/>
<person name="Jhavar S."/>
<person name="Xiao W."/>
<person name="Lim K.H."/>
<person name="Kohlhammer H."/>
<person name="Xu W."/>
<person name="Yang Y."/>
<person name="Zhao H."/>
<person name="Shaffer A.L."/>
<person name="Romesser P."/>
<person name="Wright G."/>
<person name="Powell J."/>
<person name="Rosenwald A."/>
<person name="Muller-Hermelink H.K."/>
<person name="Ott G."/>
<person name="Gascoyne R.D."/>
<person name="Connors J.M."/>
<person name="Rimsza L.M."/>
<person name="Campo E."/>
<person name="Jaffe E.S."/>
<person name="Delabie J."/>
<person name="Smeland E.B."/>
<person name="Fisher R.I."/>
<person name="Braziel R.M."/>
<person name="Tubbs R.R."/>
<person name="Cook J.R."/>
<person name="Weisenburger D.D."/>
<person name="Chan W.C."/>
<person name="Staudt L.M."/>
</authorList>
<dbReference type="PubMed" id="21179087"/>
<dbReference type="DOI" id="10.1038/nature09671"/>
</citation>
<scope>INTERACTION WITH IRAK4</scope>
<scope>VARIANTS MET-39; GLY-136; ILE-136; PHE-204; ARG-205; CYS-206; THR-207; ARG-209; THR-219; ASN-230; PRO-252 AND PRO-281</scope>
<scope>CHARACTERIZATION OF VARIANTS ARG-209; THR-219; ASN-230; PRO-252 AND PRO-281</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2013" name="Cell Rep." volume="3" first="724" last="733">
<title>IKKepsilon-mediated tumorigenesis requires K63-linked polyubiquitination by a cIAP1/cIAP2/TRAF2 E3 ubiquitin ligase complex.</title>
<authorList>
<person name="Zhou A.Y."/>
<person name="Shen R.R."/>
<person name="Kim E."/>
<person name="Lock Y.J."/>
<person name="Xu M."/>
<person name="Chen Z.J."/>
<person name="Hahn W.C."/>
</authorList>
<dbReference type="PubMed" id="23453969"/>
<dbReference type="DOI" id="10.1016/j.celrep.2013.01.031"/>
</citation>
<scope>INTERACTION WITH IKBKE</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-244</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="22">
<citation type="journal article" date="2014" name="Mol. Immunol." volume="58" first="66" last="76">
<title>Functional assessment of the mutational effects of human IRAK4 and MyD88 genes.</title>
<authorList>
<person name="Yamamoto T."/>
<person name="Tsutsumi N."/>
<person name="Tochio H."/>
<person name="Ohnishi H."/>
<person name="Kubota K."/>
<person name="Kato Z."/>
<person name="Shirakawa M."/>
<person name="Kondo N."/>
</authorList>
<dbReference type="PubMed" id="24316379"/>
<dbReference type="DOI" id="10.1016/j.molimm.2013.11.008"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH IRAK4</scope>
<scope>CHARACTERIZATION OF VARIANTS TYR-34; CYS-98 AND ILE-178</scope>
<scope>CHARACTERIZATION OF VARIANTS IMD68 GLU-52 DEL; PRO-93 AND CYS-196</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2014" name="PLoS ONE" volume="9" first="E112010" last="E112010">
<title>A TIR domain protein from E. faecalis attenuates MyD88-mediated signaling and NF-kappaB activation.</title>
<authorList>
<person name="Zou J."/>
<person name="Baghdayan A.S."/>
<person name="Payne S.J."/>
<person name="Shankar N."/>
</authorList>
<dbReference type="PubMed" id="25369374"/>
<dbReference type="DOI" id="10.1371/journal.pone.0112010"/>
</citation>
<scope>INTERACTION WITH E.FAECALIS PROTEIN TCPF (MICROBIAL INFECTION)</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2018" name="Mol. Cell" volume="69" first="505" last="516">
<title>OTUD4 Is a Phospho-Activated K63 Deubiquitinase that Regulates MyD88-Dependent Signaling.</title>
<authorList>
<person name="Zhao Y."/>
<person name="Mudge M.C."/>
<person name="Soll J.M."/>
<person name="Rodrigues R.B."/>
<person name="Byrum A.K."/>
<person name="Schwarzkopf E.A."/>
<person name="Bradstreet T.R."/>
<person name="Gygi S.P."/>
<person name="Edelson B.T."/>
<person name="Mosammaparast N."/>
</authorList>
<dbReference type="PubMed" id="29395066"/>
<dbReference type="DOI" id="10.1016/j.molcel.2018.01.009"/>
</citation>
<scope>INTERACTION WITH OTUD4</scope>
<scope>UBIQUITINATION</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2009" name="Proc. Natl. Acad. Sci. U.S.A." volume="106" first="10260" last="10265">
<title>Structural basis for the multiple interactions of the MyD88 TIR domain in TLR4 signaling.</title>
<authorList>
<person name="Ohnishi H."/>
<person name="Tochio H."/>
<person name="Kato Z."/>
<person name="Orii K.E."/>
<person name="Li A."/>
<person name="Kimura T."/>
<person name="Hiroaki H."/>
<person name="Kondo N."/>
<person name="Shirakawa M."/>
</authorList>
<dbReference type="PubMed" id="19506249"/>
<dbReference type="DOI" id="10.1073/pnas.0812956106"/>
</citation>
<scope>STRUCTURE BY NMR OF 148-296</scope>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH TIRAP AND IRAK4</scope>
<scope>MUTAGENESIS OF ARG-196; ASP-197; ARG-217; LYS-282 AND ARG-288</scope>
<scope>CHARACTERIZATION OF VARIANT IMD68 CYS-196</scope>
</reference>
<reference key="26">
<citation type="submission" date="2009-02" db="PDB data bank">
<title>Solution NMR structure of human myeloid differentiation primary response (MYD88).</title>
<authorList>
<consortium name="Northeast structural genomics consortium (NESG)"/>
</authorList>
</citation>
<scope>STRUCTURE BY NMR OF 146-296</scope>
</reference>
<reference key="27" evidence="2 3">
<citation type="journal article" date="2013" name="Proc. Natl. Acad. Sci. U.S.A." volume="110" first="6985" last="6990">
<title>Molecular mechanisms for the subversion of MyD88 signaling by TcpC from virulent uropathogenic Escherichia coli.</title>
<authorList>
<person name="Snyder G.A."/>
<person name="Cirl C."/>
<person name="Jiang J."/>
<person name="Chen K."/>
<person name="Waldhuber A."/>
<person name="Smith P."/>
<person name="Roemmler F."/>
<person name="Snyder N."/>
<person name="Fresquez T."/>
<person name="Duerr S."/>
<person name="Tjandra N."/>
<person name="Miethke T."/>
<person name="Xiao T.S."/>
</authorList>
<dbReference type="PubMed" id="23569230"/>
<dbReference type="DOI" id="10.1073/pnas.1215770110"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.45 ANGSTROMS) OF 157-296</scope>
<scope>MUTAGENESIS OF ILE-179; CYS-203 AND CYS-280</scope>
<scope>INTERACTION WITH E.COLI PROTEIN TCPC (MICROBIAL INFECTION)</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2008" name="Science" volume="321" first="691" last="696">
<title>Pyogenic bacterial infections in humans with MyD88 deficiency.</title>
<authorList>
<person name="von Bernuth H."/>
<person name="Picard C."/>
<person name="Jin Z."/>
<person name="Pankla R."/>
<person name="Xiao H."/>
<person name="Ku C.-L."/>
<person name="Chrabieh M."/>
<person name="Mustapha I.B."/>
<person name="Ghandil P."/>
<person name="Camcioglu Y."/>
<person name="Vasconcelos J."/>
<person name="Sirvent N."/>
<person name="Guedes M."/>
<person name="Vitor A.B."/>
<person name="Herrero-Mata M.J."/>
<person name="Arostegui J.I."/>
<person name="Rodrigo C."/>
<person name="Alsina L."/>
<person name="Ruiz-Ortiz E."/>
<person name="Juan M."/>
<person name="Fortuny C."/>
<person name="Yaguee J."/>
<person name="Anton J."/>
<person name="Pascal M."/>
<person name="Chang H.-H."/>
<person name="Janniere L."/>
<person name="Rose Y."/>
<person name="Garty B.-Z."/>
<person name="Chapel H."/>
<person name="Issekutz A."/>
<person name="Marodi L."/>
<person name="Rodriguez-Gallego C."/>
<person name="Banchereau J."/>
<person name="Abel L."/>
<person name="Li X."/>
<person name="Chaussabel D."/>
<person name="Puel A."/>
<person name="Casanova J.-L."/>
</authorList>
<dbReference type="PubMed" id="18669862"/>
<dbReference type="DOI" id="10.1126/science.1158298"/>
</citation>
<scope>VARIANTS IMD68 PRO-93 AND CYS-196</scope>
<scope>CHARACTERIZATION OF VARIANTS IMD68 PRO-93 AND CYS-196</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2010" name="Medicine (Baltimore)" volume="89" first="403" last="425">
<title>Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency.</title>
<authorList>
<person name="Picard C."/>
<person name="von Bernuth H."/>
<person name="Ghandil P."/>
<person name="Chrabieh M."/>
<person name="Levy O."/>
<person name="Arkwright P.D."/>
<person name="McDonald D."/>
<person name="Geha R.S."/>
<person name="Takada H."/>
<person name="Krause J.C."/>
<person name="Creech C.B."/>
<person name="Ku C.L."/>
<person name="Ehl S."/>
<person name="Marodi L."/>
<person name="Al-Muhsen S."/>
<person name="Al-Hajjar S."/>
<person name="Al-Ghonaium A."/>
<person name="Day-Good N.K."/>
<person name="Holland S.M."/>
<person name="Gallin J.I."/>
<person name="Chapel H."/>
<person name="Speert D.P."/>
<person name="Rodriguez-Gallego C."/>
<person name="Colino E."/>
<person name="Garty B.Z."/>
<person name="Roifman C."/>
<person name="Hara T."/>
<person name="Yoshikawa H."/>
<person name="Nonoyama S."/>
<person name="Domachowske J."/>
<person name="Issekutz A.C."/>
<person name="Tang M."/>
<person name="Smart J."/>
<person name="Zitnik S.E."/>
<person name="Hoarau C."/>
<person name="Kumararatne D.S."/>
<person name="Thrasher A.J."/>
<person name="Davies E.G."/>
<person name="Bethune C."/>
<person name="Sirvent N."/>
<person name="de Ricaud D."/>
<person name="Camcioglu Y."/>
<person name="Vasconcelos J."/>
<person name="Guedes M."/>
<person name="Vitor A.B."/>
<person name="Rodrigo C."/>
<person name="Almazan F."/>
<person name="Mendez M."/>
<person name="Arostegui J.I."/>
<person name="Alsina L."/>
<person name="Fortuny C."/>
<person name="Reichenbach J."/>
<person name="Verbsky J.W."/>
<person name="Bossuyt X."/>
<person name="Doffinger R."/>
<person name="Abel L."/>
<person name="Puel A."/>
<person name="Casanova J.L."/>
</authorList>
<dbReference type="PubMed" id="21057262"/>
<dbReference type="DOI" id="10.1097/md.0b013e3181fd8ec3"/>
</citation>
<scope>INVOLVEMENT IN IMD68</scope>
<scope>VARIANTS IMD68 GLU-52 DEL; PRO-93 AND CYS-196</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2012" name="N. Engl. J. Med." volume="367" first="826" last="833">
<title>MYD88 L265P somatic mutation in Waldenstrom's macroglobulinemia.</title>
<authorList>
<person name="Treon S.P."/>
<person name="Xu L."/>
<person name="Yang G."/>
<person name="Zhou Y."/>
<person name="Liu X."/>
<person name="Cao Y."/>
<person name="Sheehy P."/>
<person name="Manning R.J."/>
<person name="Patterson C.J."/>
<person name="Tripsas C."/>
<person name="Arcaini L."/>
<person name="Pinkus G.S."/>
<person name="Rodig S.J."/>
<person name="Sohani A.R."/>
<person name="Harris N.L."/>
<person name="Laramie J.M."/>
<person name="Skifter D.A."/>
<person name="Lincoln S.E."/>
<person name="Hunter Z.R."/>
</authorList>
<dbReference type="PubMed" id="22931316"/>
<dbReference type="DOI" id="10.1056/nejmoa1200710"/>
</citation>
<scope>VARIANT PRO-252</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2014" name="Blood" volume="123" first="1637" last="1646">
<title>The genomic landscape of Waldenstrom macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesis.</title>
<authorList>
<person name="Hunter Z.R."/>
<person name="Xu L."/>
<person name="Yang G."/>
<person name="Zhou Y."/>
<person name="Liu X."/>
<person name="Cao Y."/>
<person name="Manning R.J."/>
<person name="Tripsas C."/>
<person name="Patterson C.J."/>
<person name="Sheehy P."/>
<person name="Treon S.P."/>
</authorList>
<dbReference type="PubMed" id="24366360"/>
<dbReference type="DOI" id="10.1182/blood-2013-09-525808"/>
</citation>
<scope>VARIANT PRO-252</scope>
</reference>
<comment type="function">
<text evidence="7 10 14 17 20 27 32">Adapter protein involved in the Toll-like receptor and IL-1 receptor signaling pathway in the innate immune response (PubMed:15361868, PubMed:18292575). Acts via IRAK1, IRAK2, IRF7 and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response (PubMed:15361868, PubMed:24316379, PubMed:19506249). Increases IL-8 transcription (PubMed:9013863). Involved in IL-18-mediated signaling pathway. Activates IRF1 resulting in its rapid migration into the nucleus to mediate an efficient induction of IFN-beta, NOS2/INOS, and IL12A genes. MyD88-mediated signaling in intestinal epithelial cells is crucial for maintenance of gut homeostasis and controls the expression of the antimicrobial lectin REG3G in the small intestine (By similarity).</text>
</comment>
<comment type="subunit">
<text evidence="10 11 12 13 14 16 17 18 19 20 21 23 25 27 30">Homodimer. Also forms heterodimers with TIRAP. Binds to TLR2, TLR4, TLR5, IRAK1, IRAK2 and IRAK4 via their respective TIR domains. Interacts with IL18R1. Interacts with BMX, IL1RL1, IKBKE and IRF7. Interacts with LRRFIP1 and LRRFIP2; this interaction positively regulates Toll-like receptor (TLR) signaling in response to agonist. Interacts with FLII. LRRFIP1 and LRRFIP2 compete with FLII for MYD88-binding. Interacts with IRF1. Upon IL1B treatment, forms a complex with PELI1, IRAK1, IRAK4 and TRAF6; this complex recruits MAP3K7/TAK1, TAB1 and TAB2 to mediate NF-kappa-B activation. Direct binding of SMAD6 to PELI1 prevents the complex formation and hence negatively regulates IL1R-TLR signaling and eventually NF-kappa-B-mediated gene expression. May interact with PIK3AP1. Interacts (via TIR domain) with DHX9 (via H2A and OB-fold regions); this interaction is direct (PubMed:20696886). Interacts with OTUD4 deubiquitinase; the interaction is direct (PubMed:29395066).</text>
</comment>
<comment type="subunit">
<text evidence="26">(Microbial infection) In case of infection, interacts with uropathogenic E.coli protein TcpC; suppressing Toll-like receptor (TLR)-mediated cytokine production.</text>
</comment>
<comment type="subunit">
<text evidence="29">(Microbial infection) In case of infection, interacts with uropathogenic E.faecalis protein TcpF; suppressing Toll-like receptor (TLR)-mediated cytokine production.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447677">
<id>Q99836</id>
</interactant>
<interactant intactId="EBI-2548605">
<id>Q8NF50</id>
<label>DOCK8</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447677">
<id>Q99836</id>
</interactant>
<interactant intactId="EBI-494804">
<id>Q13158</id>
<label>FADD</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447677">
<id>Q99836</id>
</interactant>
<interactant intactId="EBI-301697">
<id>Q9UBN7</id>
<label>HDAC6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447677">
<id>Q99836</id>
</interactant>
<interactant intactId="EBI-358664">
<id>P51617</id>
<label>IRAK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447677">
<id>Q99836</id>
</interactant>
<interactant intactId="EBI-10249217">
<id>Q69FE3</id>
<label>IRAK4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447677">
<id>Q99836</id>
</interactant>
<interactant intactId="EBI-448378">
<id>Q9NWZ3</id>
<label>IRAK4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>15</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447677">
<id>Q99836</id>
</interactant>
<interactant intactId="EBI-447677">
<id>Q99836</id>
<label>MYD88</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>40</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447677">
<id>Q99836</id>
</interactant>
<interactant intactId="EBI-741158">
<id>Q96HA8</id>
<label>NTAQ1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447677">
<id>Q99836</id>
</interactant>
<interactant intactId="EBI-2340927">
<id>P78317</id>
<label>RNF4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447677">
<id>Q99836</id>
</interactant>
<interactant intactId="EBI-11693532">
<id>Q6SZW1</id>
<label>SARM1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447677">
<id>Q99836</id>
</interactant>
<interactant intactId="EBI-747107">
<id>Q8IUQ4</id>
<label>SIAH1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447677">
<id>Q99836</id>
</interactant>
<interactant intactId="EBI-347161">
<id>P84022</id>
<label>SMAD3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447677">
<id>Q99836</id>
</interactant>
<interactant intactId="EBI-743549">
<id>O43791</id>
<label>SPOP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447677">
<id>Q99836</id>
</interactant>
<interactant intactId="EBI-2822161">
<id>Q6IQ16</id>
<label>SPOPL</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447677">
<id>Q99836</id>
</interactant>
<interactant intactId="EBI-1553984">
<id>Q9UGK3</id>
<label>STAP2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447677">
<id>Q99836</id>
</interactant>
<interactant intactId="EBI-528644">
<id>P58753</id>
<label>TIRAP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447677">
<id>Q99836</id>
</interactant>
<interactant intactId="EBI-973722">
<id>O60603</id>
<label>TLR2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447677">
<id>Q99836</id>
</interactant>
<interactant intactId="EBI-528701">
<id>O00206</id>
<label>TLR4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447677">
<id>Q99836</id>
</interactant>
<interactant intactId="EBI-519160">
<id>O14836</id>
<label>TNFRSF13B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>12</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447677">
<id>Q99836</id>
</interactant>
<interactant intactId="EBI-594644">
<id>P10599</id>
<label>TXN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447677">
<id>Q99836</id>
</interactant>
<interactant intactId="EBI-302474">
<id>Q93009</id>
<label>USP7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447677">
<id>Q99836</id>
</interactant>
<interactant intactId="EBI-11041653">
<id>P13682</id>
<label>ZNF35</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447677">
<id>Q99836</id>
</interactant>
<interactant intactId="EBI-11616155">
<id>Q8YF33</id>
<label>BMEI1694</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447677">
<id>Q99836</id>
</interactant>
<interactant intactId="EBI-8803426">
<id>PRO_0000278740</id>
<dbReference type="UniProtKB" id="Q03463"/>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-15855480">
<id>Q99836-1</id>
</interactant>
<interactant intactId="EBI-448974">
<id>Q99418</id>
<label>CYTH2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-15855480">
<id>Q99836-1</id>
</interactant>
<interactant intactId="EBI-448378">
<id>Q9NWZ3</id>
<label>IRAK4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="10 11">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="22">Nucleus</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q99836-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q99836-2</id>
<name>2</name>
<sequence type="described" ref="VSP_038887"/>
</isoform>
<isoform>
<id>Q99836-3</id>
<name>3</name>
<sequence type="described" ref="VSP_043500"/>
</isoform>
<isoform>
<id>Q99836-4</id>
<name>4</name>
<sequence type="described" ref="VSP_043498 VSP_043499 VSP_043500"/>
</isoform>
<isoform>
<id>Q99836-5</id>
<name>5</name>
<sequence type="described" ref="VSP_053764"/>
</isoform>
<isoform>
<id>Q99836-6</id>
<name>6</name>
<sequence type="described" ref="VSP_053765"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="31">Ubiquitous.</text>
</comment>
<comment type="domain">
<text evidence="7">The intermediate domain (ID) is required for the phosphorylation and activation of IRAK.</text>
</comment>
<comment type="PTM">
<text evidence="30">Ubiquitinated; undergoes 'Lys-63'-linked polyubiquitination. OTUD4 specifically hydrolyzes 'Lys-63'-linked polyubiquitinated MYD88.</text>
</comment>
<comment type="disease" evidence="15 17 22 27">
<disease id="DI-02015">
<name>Immunodeficiency 68</name>
<acronym>IMD68</acronym>
<description>An autosomal recessive primary immunodeficiency characterized by life-threatening, often recurrent, pyogenic bacterial infections, including invasive pneumococcal disease, beginning in infancy or early childhood.</description>
<dbReference type="MIM" id="612260"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease">
<text evidence="23 24">Defects in MYD88 are frequently found in many hematological malignancies, such as activated B-cell type diffuse large B-cell lymphoma (ABC-DLBCL), Waldenstroem macroglobulinemia, cutaneous diffuse large B cell lymphoma (CBCL) and primary central nervous system lymphoma (PCNSL).</text>
</comment>
<comment type="sequence caution" evidence="35">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="BAG60822" version="1"/>
</conflict>
<text>Extended N-terminus.</text>
</comment>
<comment type="sequence caution" evidence="35">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="BAG60834" version="1"/>
</conflict>
<text>Extended N-terminus.</text>
</comment>
<comment type="sequence caution" evidence="35">
<conflict type="erroneous gene model prediction">
<sequence resource="EMBL-CDS" id="EAW64521" version="1"/>
</conflict>
</comment>
<dbReference type="EMBL" id="U70451">
<property type="protein sequence ID" value="AAB49967.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U84408">
<property type="protein sequence ID" value="AAC50954.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB446470">
<property type="protein sequence ID" value="BAG55247.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BT007376">
<property type="protein sequence ID" value="AAP36040.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK296570">
<property type="protein sequence ID" value="BAG59190.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK296716">
<property type="protein sequence ID" value="BAG59306.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK298650">
<property type="protein sequence ID" value="BAG60822.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK298666">
<property type="protein sequence ID" value="BAG60834.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AP006309">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471055">
<property type="protein sequence ID" value="EAW64521.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC013589">
<property type="protein sequence ID" value="AAH13589.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BI524129">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS2674.2">
<molecule id="Q99836-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS54565.1">
<molecule id="Q99836-6"/>
</dbReference>
<dbReference type="CCDS" id="CCDS54566.1">
<molecule id="Q99836-3"/>
</dbReference>
<dbReference type="CCDS" id="CCDS54567.1">
<molecule id="Q99836-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS54568.1">
<molecule id="Q99836-4"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001166037.1">
<molecule id="Q99836-4"/>
<property type="nucleotide sequence ID" value="NM_001172566.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001166039.1">
<molecule id="Q99836-2"/>
<property type="nucleotide sequence ID" value="NM_001172568.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001166040.1">
<molecule id="Q99836-3"/>
<property type="nucleotide sequence ID" value="NM_001172569.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_002459.2">
<molecule id="Q99836-1"/>
<property type="nucleotide sequence ID" value="NM_002468.4"/>
</dbReference>
<dbReference type="PDB" id="2JS7">
<property type="method" value="NMR"/>
<property type="chains" value="A=146-296"/>
</dbReference>
<dbReference type="PDB" id="2Z5V">
<property type="method" value="NMR"/>
<property type="chains" value="A=148-296"/>
</dbReference>
<dbReference type="PDB" id="3MOP">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.40"/>
<property type="chains" value="A/B/C/D/E/F=20-117"/>
</dbReference>
<dbReference type="PDB" id="4DOM">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=157-296"/>
</dbReference>
<dbReference type="PDB" id="4EO7">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.45"/>
<property type="chains" value="A=157-296"/>
</dbReference>
<dbReference type="PDB" id="6I3N">
<property type="method" value="EM"/>
<property type="resolution" value="3.10"/>
<property type="chains" value="A/B/C/D/E/F/G/H/I/J/K/L/M=1-151"/>
</dbReference>
<dbReference type="PDBsum" id="2JS7"/>
<dbReference type="PDBsum" id="2Z5V"/>
<dbReference type="PDBsum" id="3MOP"/>
<dbReference type="PDBsum" id="4DOM"/>
<dbReference type="PDBsum" id="4EO7"/>
<dbReference type="PDBsum" id="6I3N"/>
<dbReference type="SMR" id="Q99836"/>
<dbReference type="BioGRID" id="110700">
<property type="interactions" value="71"/>
</dbReference>
<dbReference type="DIP" id="DIP-31349N"/>
<dbReference type="IntAct" id="Q99836">
<property type="interactions" value="46"/>
</dbReference>
<dbReference type="MINT" id="Q99836"/>
<dbReference type="STRING" id="9606.ENSP00000401399"/>
<dbReference type="ChEMBL" id="CHEMBL5919"/>
<dbReference type="iPTMnet" id="Q99836"/>
<dbReference type="PhosphoSitePlus" id="Q99836"/>
<dbReference type="SwissPalm" id="Q99836"/>
<dbReference type="BioMuta" id="MYD88"/>
<dbReference type="DMDM" id="18202671"/>
<dbReference type="EPD" id="Q99836"/>
<dbReference type="jPOST" id="Q99836"/>
<dbReference type="MassIVE" id="Q99836"/>
<dbReference type="MaxQB" id="Q99836"/>
<dbReference type="PaxDb" id="Q99836"/>
<dbReference type="PeptideAtlas" id="Q99836"/>
<dbReference type="PRIDE" id="Q99836"/>
<dbReference type="ProteomicsDB" id="78500">
<molecule id="Q99836-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="78501">
<molecule id="Q99836-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="78502">
<molecule id="Q99836-3"/>
</dbReference>
<dbReference type="ProteomicsDB" id="78503">
<molecule id="Q99836-4"/>
</dbReference>
<dbReference type="TopDownProteomics" id="Q99836-4">
<molecule id="Q99836-4"/>
</dbReference>
<dbReference type="Antibodypedia" id="3965">
<property type="antibodies" value="932 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="4615"/>
<dbReference type="Ensembl" id="ENST00000396334">
<molecule id="Q99836-1"/>
<property type="protein sequence ID" value="ENSP00000379625"/>
<property type="gene ID" value="ENSG00000172936"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000421516">
<molecule id="Q99836-6"/>
<property type="protein sequence ID" value="ENSP00000391753"/>
<property type="gene ID" value="ENSG00000172936"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000424893">
<molecule id="Q99836-2"/>
<property type="protein sequence ID" value="ENSP00000389979"/>
<property type="gene ID" value="ENSG00000172936"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000443433">
<molecule id="Q99836-3"/>
<property type="protein sequence ID" value="ENSP00000390565"/>
<property type="gene ID" value="ENSG00000172936"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000495303">
<molecule id="Q99836-4"/>
<property type="protein sequence ID" value="ENSP00000417848"/>
<property type="gene ID" value="ENSG00000172936"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000650905">
<molecule id="Q99836-1"/>
<property type="protein sequence ID" value="ENSP00000498360"/>
<property type="gene ID" value="ENSG00000172936"/>
</dbReference>
<dbReference type="GeneID" id="4615"/>
<dbReference type="KEGG" id="hsa:4615"/>
<dbReference type="UCSC" id="uc011ayj.3">
<molecule id="Q99836-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="4615"/>
<dbReference type="DisGeNET" id="4615"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000172936.12"/>
<dbReference type="GeneCards" id="MYD88"/>
<dbReference type="HGNC" id="HGNC:7562">
<property type="gene designation" value="MYD88"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000172936">
<property type="expression patterns" value="Tissue enhanced (blood)"/>
</dbReference>
<dbReference type="MalaCards" id="MYD88"/>
<dbReference type="MIM" id="602170">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="612260">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q99836"/>
<dbReference type="OpenTargets" id="ENSG00000172936"/>
<dbReference type="Orphanet" id="183713">
<property type="disease" value="Bacterial susceptibility due to TLR signaling pathway deficiency"/>
</dbReference>
<dbReference type="Orphanet" id="33226">
<property type="disease" value="Waldenstroem macroglobulinemia"/>
</dbReference>
<dbReference type="PharmGKB" id="PA31361"/>
<dbReference type="eggNOG" id="ENOG502QWKI">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00510000048324"/>
<dbReference type="HOGENOM" id="CLU_116540_0_0_1"/>
<dbReference type="InParanoid" id="Q99836"/>
<dbReference type="KO" id="K04729"/>
<dbReference type="PhylomeDB" id="Q99836"/>
<dbReference type="TreeFam" id="TF326264"/>
<dbReference type="PathwayCommons" id="Q99836"/>
<dbReference type="Reactome" id="R-HSA-1236974">
<property type="pathway name" value="ER-Phagosome pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1257604">
<property type="pathway name" value="PIP3 activates AKT signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-166058">
<property type="pathway name" value="MyD88:MAL(TIRAP) cascade initiated on plasma membrane"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1810476">
<property type="pathway name" value="RIP-mediated NFkB activation via ZBP1"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-209543">
<property type="pathway name" value="p75NTR recruits signalling complexes"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3134963">
<property type="pathway name" value="DEx/H-box helicases activate type I IFN and inflammatory cytokines production"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5602498">
<property type="pathway name" value="MyD88 deficiency (TLR2/4)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5602680">
<property type="pathway name" value="MyD88 deficiency (TLR5)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5603037">
<property type="pathway name" value="IRAK4 deficiency (TLR5)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5603041">
<property type="pathway name" value="IRAK4 deficiency (TLR2/4)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6811558">
<property type="pathway name" value="PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9020702">
<property type="pathway name" value="Interleukin-1 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-975110">
<property type="pathway name" value="TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-975138">
<property type="pathway name" value="TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-975155">
<property type="pathway name" value="MyD88 dependent cascade initiated on endosome"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-975871">
<property type="pathway name" value="MyD88 cascade initiated on plasma membrane"/>
</dbReference>
<dbReference type="SignaLink" id="Q99836"/>
<dbReference type="SIGNOR" id="Q99836"/>
<dbReference type="BioGRID-ORCS" id="4615">
<property type="hits" value="18 hits in 872 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="MYD88">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q99836"/>
<dbReference type="GeneWiki" id="MYD88"/>
<dbReference type="GenomeRNAi" id="4615"/>
<dbReference type="Pharos" id="Q99836">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q99836"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 3"/>
</dbReference>
<dbReference type="RNAct" id="Q99836">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000172936">
<property type="expression patterns" value="Expressed in blood and 233 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q99836">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="AgBase"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0010008">
<property type="term" value="C:endosome membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="AgBase"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0014069">
<property type="term" value="C:postsynaptic density"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032991">
<property type="term" value="C:protein-containing complex"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005123">
<property type="term" value="F:death receptor binding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0005149">
<property type="term" value="F:interleukin-1 receptor binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043621">
<property type="term" value="F:protein self-association"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="AgBase"/>
</dbReference>
<dbReference type="GO" id="GO:0070976">
<property type="term" value="F:TIR domain binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005121">
<property type="term" value="F:Toll binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0035325">
<property type="term" value="F:Toll-like receptor binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0070935">
<property type="term" value="P:3'-UTR-mediated mRNA stabilization"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006915">
<property type="term" value="P:apoptotic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="AgBase"/>
</dbReference>
<dbReference type="GO" id="GO:0007166">
<property type="term" value="P:cell surface receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0071222">
<property type="term" value="P:cellular response to lipopolysaccharide"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0071260">
<property type="term" value="P:cellular response to mechanical stimulus"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0140052">
<property type="term" value="P:cellular response to oxidised low-density lipoprotein particle stimulus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042742">
<property type="term" value="P:defense response to bacterium"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0050830">
<property type="term" value="P:defense response to Gram-positive bacterium"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042832">
<property type="term" value="P:defense response to protozoan"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0090557">
<property type="term" value="P:establishment of endothelial intestinal barrier"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0016064">
<property type="term" value="P:immunoglobulin mediated immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0009682">
<property type="term" value="P:induced systemic resistance"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0070498">
<property type="term" value="P:interleukin-1-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007254">
<property type="term" value="P:JNK cascade"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0031663">
<property type="term" value="P:lipopolysaccharide-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0002755">
<property type="term" value="P:MyD88-dependent toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0043066">
<property type="term" value="P:negative regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006909">
<property type="term" value="P:phagocytosis"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045080">
<property type="term" value="P:positive regulation of chemokine biosynthetic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1900017">
<property type="term" value="P:positive regulation of cytokine production involved in inflammatory response"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010628">
<property type="term" value="P:positive regulation of gene expression"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043123">
<property type="term" value="P:positive regulation of I-kappaB kinase/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032740">
<property type="term" value="P:positive regulation of interleukin-17 production"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032747">
<property type="term" value="P:positive regulation of interleukin-23 production"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032755">
<property type="term" value="P:positive regulation of interleukin-6 production"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032757">
<property type="term" value="P:positive regulation of interleukin-8 production"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046330">
<property type="term" value="P:positive regulation of JNK cascade"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0050671">
<property type="term" value="P:positive regulation of lymphocyte proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051092">
<property type="term" value="P:positive regulation of NF-kappaB transcription factor activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="AgBase"/>
</dbReference>
<dbReference type="GO" id="GO:0048661">
<property type="term" value="P:positive regulation of smooth muscle cell proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032760">
<property type="term" value="P:positive regulation of tumor necrosis factor production"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032481">
<property type="term" value="P:positive regulation of type I interferon production"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:2000338">
<property type="term" value="P:regulation of chemokine (C-X-C motif) ligand 1 production"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:2000341">
<property type="term" value="P:regulation of chemokine (C-X-C motif) ligand 2 production"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0050727">
<property type="term" value="P:regulation of inflammatory response"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1902622">
<property type="term" value="P:regulation of neutrophil migration"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0070555">
<property type="term" value="P:response to interleukin-1"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0002238">
<property type="term" value="P:response to molecule of fungal origin"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032494">
<property type="term" value="P:response to peptidoglycan"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0009615">
<property type="term" value="P:response to virus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0008063">
<property type="term" value="P:Toll signaling pathway"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0034162">
<property type="term" value="P:toll-like receptor 9 signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0002224">
<property type="term" value="P:toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0032606">
<property type="term" value="P:type I interferon production"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060337">
<property type="term" value="P:type I interferon signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="CDD" id="cd08312">
<property type="entry name" value="Death_MyD88"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.10140">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR011029">
<property type="entry name" value="DEATH-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000488">
<property type="entry name" value="Death_domain"/>
</dbReference>
<dbReference type="InterPro" id="IPR034249">
<property type="entry name" value="MyD88_Death"/>
</dbReference>
<dbReference type="InterPro" id="IPR017281">
<property type="entry name" value="Myelin_different_resp_MyD88"/>
</dbReference>
<dbReference type="InterPro" id="IPR000157">
<property type="entry name" value="TIR_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR035897">
<property type="entry name" value="Toll_tir_struct_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR15079">
<property type="entry name" value="PTHR15079"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00531">
<property type="entry name" value="Death"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01582">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF037756">
<property type="entry name" value="MyD88"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00005">
<property type="entry name" value="DEATH"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00255">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF47986">
<property type="entry name" value="SSF47986"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52200">
<property type="entry name" value="SSF52200"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50017">
<property type="entry name" value="DEATH_DOMAIN"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50104">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0395">Inflammatory response</keyword>
<keyword id="KW-0399">Innate immunity</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Myeloid differentiation primary response protein MyD88" id="PRO_0000096666">
<location>
<begin position="1"/>
<end position="296"/>
</location>
</feature>
<feature type="domain" description="Death" evidence="8">
<location>
<begin position="54"/>
<end position="109"/>
</location>
</feature>
<feature type="domain" description="TIR" evidence="9">
<location>
<begin position="159"/>
<end position="293"/>
</location>
</feature>
<feature type="region of interest" description="Intermediate domain" evidence="6">
<location>
<begin position="110"/>
<end position="155"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5">
<location>
<position position="244"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 5." id="VSP_053764" evidence="33">
<original>MAAGGPGAGSAAPVSSTSSLPL</original>
<variation>M</variation>
<location>
<begin position="1"/>
<end position="22"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_038887" evidence="33">
<location>
<begin position="110"/>
<end position="154"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_043498" evidence="33">
<original>E</original>
<variation>G</variation>
<location>
<position position="110"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_043499" evidence="33">
<location>
<begin position="111"/>
<end position="155"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3 and isoform 4." id="VSP_043500" evidence="33">
<original>HMPERFDAFICYCPSDIQFVQEMIRQLEQTNYRLKLCVSDRDVLPGTCVWSIASELIEKRCRRMVVVVSDDYLQSKECDFQTKFALSLSPGAHQKRLIPIKYKAMKKEFPSILRFITVCDYTNPCTKSWFWTRLAKALSLP</original>
<variation>AAGWWWLSLMITCRARNVTSRPNLHSASLQVPIRSD</variation>
<location>
<begin position="156"/>
<end position="296"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 6." id="VSP_053765" evidence="34">
<original>R</original>
<variation>RLARRPRGG</variation>
<location>
<position position="215"/>
</location>
</feature>
<feature type="sequence variant" description="Rare functional polymorphism; loss of NF-kappa-B complex activation; loss of interaction with IRAK4; reduces homooligomerization; dbSNP:rs1319438." id="VAR_072893" evidence="21 27">
<original>S</original>
<variation>Y</variation>
<location>
<position position="34"/>
</location>
</feature>
<feature type="sequence variant" description="Found in hematological malignancies; somatic mutation; unknown pathological significance; dbSNP:rs770387646." id="VAR_073252" evidence="23">
<original>V</original>
<variation>M</variation>
<location>
<position position="39"/>
</location>
</feature>
<feature type="sequence variant" description="In IMD68; loss of NF-kappa-B complex activation." id="VAR_072894" evidence="22 27">
<location>
<position position="52"/>
</location>
</feature>
<feature type="sequence variant" description="In IMD68; results in a loss of function; loss of NF-kappa-B complex activation; dbSNP:rs137853065." id="VAR_047953" evidence="15 22 27">
<original>L</original>
<variation>P</variation>
<location>
<position position="93"/>
</location>
</feature>
<feature type="sequence variant" description="Found in hematological malignancies; somatic mutation; unknown pathological significance; loss of NF-kappa-B complex activation; loss of interaction with IRAK4; reduces homooligomerization; dbSNP:rs199396." id="VAR_072895" evidence="21 27 31">
<original>R</original>
<variation>C</variation>
<location>
<position position="98"/>
</location>
</feature>
<feature type="sequence variant" description="Found in hematological malignancies; somatic mutation; unknown pathological significance." id="VAR_073253" evidence="23">
<original>S</original>
<variation>G</variation>
<location>
<position position="136"/>
</location>
</feature>
<feature type="sequence variant" description="Found in hematological malignancies; somatic mutation; unknown pathological significance." id="VAR_073254" evidence="23">
<original>S</original>
<variation>I</variation>
<location>
<position position="136"/>
</location>
</feature>
<feature type="sequence variant" description="Found in hematological malignancies; somatic mutation; unknown pathological significance; no effect on NF-kappaB complex activation; dbSNP:rs41285117." id="VAR_072896" evidence="21 27">
<original>M</original>
<variation>I</variation>
<location>
<position position="178"/>
</location>
</feature>
<feature type="sequence variant" description="In IMD68; results in a loss of function; decreases NF-kappa-B complex activation; dbSNP:rs137853064." id="VAR_047954" evidence="15 17 22 27">
<original>R</original>
<variation>C</variation>
<location>
<position position="196"/>
</location>
</feature>
<feature type="sequence variant" description="Found in hematological malignancies; somatic mutation; unknown pathological significance; dbSNP:rs776995408." id="VAR_073255" evidence="23">
<original>V</original>
<variation>F</variation>
<location>
<position position="204"/>
</location>
</feature>
<feature type="sequence variant" description="Found in hematological malignancies; somatic mutation; unknown pathological significance." id="VAR_073256" evidence="23">
<original>W</original>
<variation>R</variation>
<location>
<position position="205"/>
</location>
</feature>
<feature type="sequence variant" description="Found in hematological malignancies; somatic mutation; unknown pathological significance." id="VAR_073257" evidence="23">
<original>S</original>
<variation>C</variation>
<location>
<position position="206"/>
</location>
</feature>
<feature type="sequence variant" description="Found in hematological malignancies; somatic mutation; unknown pathological significance." id="VAR_073258" evidence="23">
<original>I</original>
<variation>T</variation>
<location>
<position position="207"/>
</location>
</feature>
<feature type="sequence variant" description="Found in hematological malignancies; somatic mutation; unknown pathological significance; constitutively activates NF-kappaB complex activation." id="VAR_073259" evidence="23">
<original>S</original>
<variation>R</variation>
<location>
<position position="209"/>
</location>
</feature>
<feature type="sequence variant" description="Found in hematological malignancies; somatic mutation; unknown pathological significance; constitutively activates NF-kappaB complex activation." id="VAR_073260" evidence="23">
<original>M</original>
<variation>T</variation>
<location>
<position position="219"/>
</location>
</feature>
<feature type="sequence variant" description="Found in hematological malignancies; somatic mutation; unknown pathological significance; constitutively activates NF-kappaB complex activation; dbSNP:rs1353791431." id="VAR_073261" evidence="23">
<original>S</original>
<variation>N</variation>
<location>
<position position="230"/>
</location>
</feature>
<feature type="sequence variant" description="Found in hematological malignancies; common mutation in Waldenstroem macroglobulinemia; somatic mutation; unknown pathological significance; constitutively activates NF-kappaB complex activation; gain-of-function mutation; does not affect interaction with IRAK4; dbSNP:rs387907272." id="VAR_073262" evidence="23 24 28">
<original>L</original>
<variation>P</variation>
<location>
<position position="252"/>
</location>
</feature>
<feature type="sequence variant" description="Found in hematological malignancies; somatic mutation; unknown pathological significance; no effect on NF-kappaB complex activation." id="VAR_073263" evidence="23">
<original>T</original>
<variation>P</variation>
<location>
<position position="281"/>
</location>
</feature>
<feature type="mutagenesis site" description="In Pococurante (Poc); abolished MYD88-dependent sensing of most Toll-like receptor (TLR) ligands." evidence="26">
<original>I</original>
<variation>N</variation>
<location>
<position position="179"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced interaction with TIRAP, and strongly reduced activity. Strongly reduced interaction with TIRAP; when associated with A-288." evidence="17">
<original>R</original>
<variation>A</variation>
<location>
<position position="196"/>
</location>
</feature>
<feature type="mutagenesis site" description="Slightly reduced activity." evidence="17">
<original>D</original>
<variation>A</variation>
<location>
<position position="197"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolished interaction with E.coli TcpC without affecting ability to promote Toll-like receptor (TLR)-mediated cytokine production; when associated with S-280." evidence="26">
<original>C</original>
<variation>S</variation>
<location>
<position position="203"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced activity." evidence="17">
<original>R</original>
<variation>A</variation>
<location>
<position position="217"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolished interaction with E.coli TcpC without affecting ability to promote Toll-like receptor (TLR)-mediated cytokine production; when associated with S-203." evidence="26">
<original>C</original>
<variation>S</variation>
<location>
<position position="280"/>
</location>
</feature>
<feature type="mutagenesis site" description="Slightly reduced activity." evidence="17">
<original>K</original>
<variation>A</variation>
<location>
<position position="282"/>
</location>
</feature>
<feature type="mutagenesis site" description="Slightly reduced activity, and reduced interaction with TIRAP. Strongly reduced interaction with TIRAP; when associated with A-196." evidence="17">
<original>R</original>
<variation>A</variation>
<location>
<position position="288"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 8; BI524129." ref="8" evidence="35">
<original>K</original>
<variation>T</variation>
<location>
<position position="190"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 8; BI524129." ref="8" evidence="35">
<original>VS</original>
<variation>WL</variation>
<location>
<begin position="223"/>
<end position="224"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="22"/>
<end position="24"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="27"/>
<end position="37"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="42"/>
<end position="44"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="47"/>
<end position="53"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="58"/>
<end position="64"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="66"/>
<end position="69"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="70"/>
<end position="77"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="79"/>
<end position="81"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="86"/>
<end position="95"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="100"/>
<end position="104"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="106"/>
<end position="120"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="159"/>
<end position="166"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="169"/>
<end position="171"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="172"/>
<end position="183"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="185"/>
<end position="187"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="191"/>
<end position="194"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="196"/>
<end position="198"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="209"/>
<end position="211"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="212"/>
<end position="215"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="216"/>
<end position="223"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="227"/>
<end position="229"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="231"/>
<end position="242"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="247"/>
<end position="251"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="252"/>
<end position="256"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="266"/>
<end position="268"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="269"/>
<end position="271"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="279"/>
<end position="281"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="285"/>
<end position="294"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3MOP"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4DOM"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4EO7"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6I3N"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000250"/>
<evidence key="7" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P22366"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00064"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00204"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15361868"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15492225"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16286016"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16951688"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18292575"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18669862"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19265123"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19506249"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19948740"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20696886"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20855887"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20966070"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21057262"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21179087"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22931316"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23453969"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23569230"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24316379"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24366360"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25369374"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="29395066"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8957090"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9013863"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000305"/>
<evidence key="36" type="ECO:0000312">
<source>
<dbReference type="HGNC" id="HGNC:7562"/>
</source>
</evidence>
<sequence length="296" mass="33233" checksum="CEAE3F6B99524333" modified="1997-05-01" version="1">MAAGGPGAGSAAPVSSTSSLPLAALNMRVRRRLSLFLNVRTQVAADWTALAEEMDFEYLEIRQLETQADPTGRLLDAWQGRPGASVGRLLELLTKLGRDDVLLELGPSIEEDCQKYILKQQQEEAEKPLQVAAVDSSVPRTAELAGITTLDDPLGHMPERFDAFICYCPSDIQFVQEMIRQLEQTNYRLKLCVSDRDVLPGTCVWSIASELIEKRCRRMVVVVSDDYLQSKECDFQTKFALSLSPGAHQKRLIPIKYKAMKKEFPSILRFITVCDYTNPCTKSWFWTRLAKALSLP</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

